ONDOSIS
OnDosis proprietary technology delivers flexible and individualized dosing of oral medicines formulated as micro units. They are focused on providing reassurance in disease management, supporting adherence and providing greater convenience for patients. OnDosis is currently developing products for individualized dosing in diseases with a significant burden on patients and healthcare such as ADHD, pain management and immunosuppression for organ transplants. Hundreds of thousands of patients with ... these conditions could be helped by improved dosing, ultimately leading to improving health care outcomes. The flexibility of OnDosis technology provides the potential for application across several disease areas and patient segments where conventional tablets or capsules often does not provide a good fit for the patient or treatment goal. OnDosis was founded in 2017 and is headquartered in Gothenburg, Sweden, based on an idea that was spun-out from AstraZeneca, using technology based on development work initiated there. It was founded by GU Ventures and Martin Olovsson. OnDosis operates a network of strategic partners across all core functions including formulation and device development, IP, Regulatory and Business Development.
ONDOSIS
Industry:
Pharmaceutical
Founded:
2017-01-01
Address:
Mölndal, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.ondosis.com
Total Employee:
11+
Status:
Active
Total Funding:
14.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Google Universal Analytics Euro CloudFront Typekit Microsoft Microsoft Azure
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
OMass Technologies
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Synapse Medicine
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Board_member
Current Employees Featured
Martin Olovsson CEO and Co-founder @ OnDosis
CEO and Co-founder
Founder
Investors List
DIG Investment
DIG Investment investment in Venture Round - OnDosis
Aeternum Management
Aeternum Management investment in Venture Round - OnDosis
Albonja
Albonja investment in Venture Round - OnDosis
AstraZeneca
AstraZeneca investment in Seed Round - OnDosis
DIG Investment
DIG Investment investment in Seed Round - OnDosis
GU Ventures
GU Ventures investment in Seed Round - OnDosis
Horizon 2020
Horizon 2020 investment in Grant - OnDosis
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - OnDosis
Official Site Inspections
http://www.ondosis.com Semrush global rank: 9.98 M Semrush visits lastest month: 70
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OnDosis"
OnDosis
OnDosis is an AstraZeneca spin-out founded in Gothenburg in 2017. From the outset, the team has focused on improving how oral solids are dosed, to meet the increasing needs for personalization of medicines. A scalable platform …See details»
OnDosis - Crunchbase Company Profile & Funding
Organization. OnDosis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. OnDosis is a Swedish life science start-up. …See details»
OnDosis
Before joining OnDosis in 2019, he was working at EY Advisory Services, leading strategic projects for clients, for example within healthcare, med tech and pharmacy industry. Stina …See details»
OnDosis - LinkedIn
OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. OnDosis | 1,769 followers on LinkedIn. OnDosis is ...See details»
OnDosis Company Profile 2024: Valuation, Funding & Investors
OnDosis General Information Description. Developer of a personalized medicine device intended to revolutionize the way patients take their medicines. The company offers a dosage manager …See details»
Introducing OnDosis, a new life science company
OnDosis has also been supported by students in the Entrepreneurship in Life Sciences program at Sahlgrenska Academy within the University of Gothenburg and by GU Project Accelerator …See details»
OnDosis - Products, Competitors, Financials, Employees, …
About OnDosis. OnDosis is a company focused on revolutionizing medication intake, operating in the healthcare and technology sectors. The company offers an intuitive Dosage Manager and …See details»
OnDosis Company Profile - Office Locations, Competitors ... - Craft
OnDosis is a life science company developing a medical handheld device with intelligent dosing and digital capability. Its proprietary technology delivers flexible and individualized dosing of …See details»
New agreement expands collaboration between …
May 26, 2021 The team at OnDosis consists of experts in developing and designing proprietary solutions, including intuitive, user-friendly, and connected devices that deliver medicine and enables digital solutions to be integrated. ...See details»
OnDosis
Who we are OnDosis is a B2B company providing a solution for individualized treatments by bringing an innovative technology applicable for oral solids. Through our collaborations with leading pharmaceutical companies, we …See details»
Tiefenbacher Group and OnDosis enter a strategic partnership for ...
Sep 3, 2020 About OnDosis. Founded as a spin-out from AstraZeneca in 2017, OnDosis is a Swedish start-up addressing one of the major opportunities in healthcare; personalized …See details»
New agreement expands collaboration between OnDosis and …
May 26, 2021 The team at OnDosis consists of experts in developing and designing proprietary solutions, including intuitive, user-friendly, and connected devices that deliver medicine and …See details»
TIEFENBACHER GROUP and OnDosis launch the innovative …
Oct 25, 2022 For interest in any other indication or solely the device please contact OnDosis: Dr. Kristian Ruepp Joint Managing Director, TIEFENBACHER GROUP. Tel: +49 40 – 44 18 09-0; …See details»
OnDosis
OnDosis is a Domain Driven solution, allowing for flexible, stable and secure environment to meet the markets ever changing needs as well as regulatory demand. The Platform allows …See details»
TIEFENBACHER GROUP and OnDosis launch the innovative …
Oct 25, 2022 TIEFENBACHER GROUP and OnDosis today announced the launch of the OYSTA® brand.OYSTA® represents the extensive co-development portfolio of drug/device …See details»
Camallergy and OnDosis Announce a Groundbreaking Partnership …
Nov 29, 2023 About OnDosis A Swedish Life science company that will revolutionize the way patients take their medicines. The idea is to deliver the perfect dosage—individualized, …See details»
OnDosis
OnDosis solutions has the potential to improve outcomes. Thanks to the handheld and easy-to-use Dosage Manager, and in combination with services, we enable closed loop disease …See details»
Tiefenbacher Group and OnDosis enter a strategic partnership for …
Sep 3, 2020 Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration …See details»
OnDosis
The OnDosis Solution. Our solution combines easy-to-use hardware with intuitive software. Our first in class Dosage Manager delivers oral solid prescription medicine as granules, pellets or …See details»